Solaraze 3%, Gel

7680605800057 CH-60580 Gel

Associated product:

SOLARAZE gel 3 % tb 25 g
Solaraze 3%, Gel
Solaraze 3%, Gel
Solaraze 3%, Gel
1 / 3
google

Article details

Package size
25
Selling units
25
Measure
g
Galenic form
Gel
Galenic group
Salben

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
10/02/2021
Patient information leaflet
Français
10/02/2021
Patient information leaflet
Italien
10/02/2021
Summary of Product Characteristics
Allemand
10/02/2021
Summary of Product Characteristics
Français
10/02/2021
Summary of Product Characteristics
Italien
10/02/2021

Detailed composition

Substance Quantity Type Category
(N/A)
30.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
10.0 MG Substance HBESI

Reimbursement information

Public price
CHF 33.25
Specialties list
Yes
Generic
No
SL addition date: 01/05/2011

Authorization holder

Almirall AG

8304 Wallisellen

Authorization information

Swissmedic authorization number
60580
Drug name
Solaraze 3%, Gel
Galenic form
GELK
ATC Code
D11AX18
Authorization status
Z
Dispensing category
B
First authorization
23/12/2010
Authorization expiration date
31/12/9999
IT Number
10.99.0.
Domain
Human medicine
Field of application
Behandlung aktinische Keratose

Package details

Description (FR)
SOLARAZE gel 3 % tb 25 g
Description (DE)
SOLARAZE Gel 3 % Tb 25 g
Market launch
23/12/2010
Narcotic (BTM)
No

Available generics (2)

Solacutan 3%, Gel
GTIN: 7680666440018
CHF 30.85
View
Solacutan 3%, Gel
GTIN: 7680666440025
CHF 41.80
View

Other package sizes (2)

SOLARAZE gel 3 % tb 50 g
50 G
GTIN: 7680605800019
View
None
100 G
GTIN: None
Not in V1